Furthermore, in breast cancer, CCL2 and CCL5 expression is restricted not only to tumor cells but also to cells of the tumor microenvironment, including fibroblasts, endothelial cells, mesenchymal stem cells, smooth muscle cells and immune cells such as tumor-associated macrophages and T cells [20]. Here, CCL2 is linked to neoplasm.